MEDNAX (MD) Misses Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/8/2026
- S&P 500, Nasdaq rise as tech, chipmakers rebound
- Oil prices settle $1 higher after Iran and Israel say they have halted attacks
- Tech stocks gain as Trump mulls government stake in AI companies
- Morgan Stanley’s Wilson calls Friday U.S. selloff a "healthy reset"
- Hedge funds loaded up on equities ahead of sharp Friday drop
- Powerful Philippine quake leaves at least 32 feared dead, survivors recount fear
- Exclusive-SpaceX plans to set IPO price at $135 per share, targeting record $75 billion raise, source says
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- Salesforce to acquire metering platform M3TER for consumption billing
- SpaceX sets $135 price for blockbuster IPO, upending Wall Street convention
MEDNAX Reports First Quarter GAAP EPS of $0.59; Adjusted EPS of $0.75
May 4, 2017 6:00 AM EDTFORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, maternal-fetal medicine, other pediatric services, radiology, and management services, today reported earnings of $0.59 per diluted share for the three months ended March 31, 2017. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $0.75.
For the 2017 first quarter, MEDNAX reported the following results as compared to the first quarter of 2016:
Net revenue of $836 million, compared to $753 million; Net income of $55 million, compared to $68 million; and EBITDA of $132... More